This inventor holds 5 USPTO granted patents and 1 published patent application, plus 4 CIPO patents and 1 EPO patent. Top assignees: Centre National De La Recherche Scientifique, Aventis Pharma S.a., Ecole Nationale Superieure De Chime De Rennes. Active years: 2000-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Paris, FR (2000 - 2010)
- Brest, FR (2012 - 2019)
Company Filing History:
3 out of 5,383 
2 out of 377 
1 out of 1 
Years Active: 2000-2019
Title: Pierre Lehn: Innovator in Pharmaceutical Compounds
Introduction
Pierre Lehn is a notable inventor based in Brest, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for treating cystic fibrosis. With a total of 5 patents, his work has the potential to impact many lives.
Latest Patents
One of his latest patents involves compounds for treating cystic fibrosis. This invention relates to compounds of Formula (I) or pharmaceutically acceptable enantiomers, salts, solvates, or prodrugs thereof. The invention further explores the use of these compounds for the treatment of cystic fibrosis and includes a process for manufacturing them. Another significant patent focuses on analogue compounds of archaebacterial membrane lipids and liposomal compounds integrating such compounds. This invention describes a compound of general formula (I) with various components, including directing agents and different types of bonds.
Career Highlights
Throughout his career, Pierre Lehn has worked with esteemed organizations such as the Centre National de la Recherche Scientifique and Aventis Pharma S.A. His experience in these institutions has allowed him to refine his expertise in pharmaceutical research and development.
Collaborations
Pierre has collaborated with notable individuals in his field, including Jean-Marie Lehn and Jean-Pierre Vigneron. These collaborations have likely contributed to his innovative approaches and successful patent applications.
Conclusion
Pierre Lehn's contributions to pharmaceutical innovations, particularly in cystic fibrosis treatment, highlight his role as a significant inventor. His patents reflect a commitment to advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile